Abstract
The informational aspects of nucleic acid synthesis have attracted much more attention than the quantitative significance of DNA, rRNA, tRNA, and nucleotide synthesis. Animal and human studies suggest that in energetic terms, 5-10% of the energy used in synthesising tissue protein is expended in manufacturing an appropriate amount of synthetic machinery, that is the ribosome and tRNA. The two sources for synthesis of nucleotides are salvage of nucleotides released by intracellular degradation or derived from the diet, and nucleotides synthesised de novo from amino acids (for example, glutamine) and sugars (glucose). The comparative importance of these two processes is not well defined, but rRNA production requires a high de novo input in cell types with the capacity for rapid division (for example, lymphocytes). The Nucleic acids are not thought to be essential nutrients as pathways exist for synthesis of purines and pyrimidines, de novo. Most recent basic nucleic acid research has concentrated on the 'informational' aspects, rather than 'metabolic' aspects of their metabolism. Examples would include modulation of cytokine mRNA concentrations1 or muscle ribosome concentrations as mediators of posttraumatic changes in protein synthesis. 2 This paper will define several factors related to dietary provision of nucleotides (Table) . How are synthetic pathways for purine and pyrimidines affected by the dietary intake of purines and pyrimidines? What is the nature of purine and pyrimidine requirements and can endogenous purine and pyrimidine supply ever be exceeded by demand in the acutely ill patient? Will organ function be impaired by no intake of purines and pyrimidines as occurs for most patients fed with most current enteral and parenteral formulas?
Pathways of purine and pyrimidine biosynthesis Endogenous purines and pyrimidines are synthesised de novo, from amino acids and other small molecules. The two pathways differ in that the ribose moiety of purine nucleosides is incorporated as 5-phosphoribosyl-l-phosphate (PRPP) in the first reaction of purine synthesis, but for pyrimidines is incorporated at the end stage after the pyrimidine ring has been fully formed, as reviewed elsewhere.3-5
SYNTHESIS
Endogenous purines and pyrimidines are synthesised de novo, from amino acids and other small molecules (Fig 1) . Pyrimidines are synthesised from NH3, CO2, and aspartate, the This may relate to the low capacity of intestinal transport mechanisms that exist for all four purine/pyrimidine bases8-10 as excess intake is fermented by colonic bacteria.
Savaiano et a17 saw that those tissues most actively participating in nucleic acid synthesis had the highest incorporation ratio (14C intravenous: 14C oral) and included salivary, adrenal, thyroid, thymus and pituitary glands, and lymph tissue (ratio 25-59), whereas it was only three for liver. Similar results have been obtained in rats infused with nucleoside/ nucleotide mixtures.11 Adenine could be taken up intact by the gut, whereas guanine, hypoxanthine, and xanthine were extensively catabolised in their passage from mucosa to serosa, implying that the gut has low capacity for de novo adenine synthesis.12 This would explain the different fate of oral or intravenous purines on the basis of the gut mucosa's high requirement for exogenous purines, which results in preferential extraction of luminal nucleotides during first pass through gut and liver. 13 A reciprocal relation between purine intake It is synthesised in the nucleolus by RNA polymerase I, which is separately regulated from the other nuclear polymerases. The primary transcript, 45 S pre-rRNA, is cleaved to 18S and 28S rRNA species, which exit the nucleus as mature 40S and 60S ribosomal subunits (Fig 2) . A significant proportion of unmethylated 'spacer' region of pre-rRNA is degraded during processing. As such their nucleotides can enter the salvage pathway for subsequent reutilisation in RNA synthesis (see reviews by Warner29 30) . In non-growing tissues, a further proportion (up to 50%) of the 45S pre-RNA is degraded completely, termed 'wastage'.
The supply of rRNA and ribosomal proteins is coordinated because if rRNA synthesis is inhibited, degradation of nucleolar rProteins increases31 32 whereas if rProtein synthesis is inhibited, there is increased degradation of 45S pre-rRNA. 24 3 This apparently expensive process ('wastage') that is loosely coupled torProtein synthesis, gives exquisite control of cytoplasmic ribosome appearance rates. Warner29-31 has aptly called the inhibitory modulation of excess rRNA and rProtein concentrations (through degradation), 'fine tuning' of ribosome supply. The level of 'coarse tuning' would be supplied by gross coordinate changes in rProtein and rRNA synthesis in response to growth or nutritional depletion. RIBOSOME PRODUCTION AND GROWTH STIMULI Liver The two phases of liver regeneration in the rat can be described as 'proliferative' (days 1-5) and 'post-proliferative' (days 6-12 The growth stimulus to lymphocytes, provided by the mitogen phytohaemagglutinin (PHA) is mediated in large part by increased ribosome production (10 to 50-fold), which comes before DNA replication and cell division.56
This model thus represents an extreme anabolic stress and as in hypertrophying kidney, the increase in ribosome production is achieved through the end of the 'wastage' of 45S pre-rRNA in resting cells. As described, this mechanism permits rapid increases in ribosome production at the least energetic S48 group.bmj.com on June 21, 2017 -Published by http://gut.bmj.com/ Downloaded from cost. De novo synthesis provides most of the nucleotide flux for increased RNA and DNA synthesis, as suggested by the limited ability of exogenous nucleobases and nucleosides (salvage pathway) to relieve inhibition of growth by limiting amounts of glutamine in the culture medium (de novo pathway).57 RESPONSES OF PURINE, PYRIMIDINE, AND RIBOSOME METABOLISM TO GROWTH STIMULI Where protein intake is adequate, de novo synthesis provides the main source of nucleotides for nucleic acid synthesis. Although it can be suppressed by dietary purine and pyrimidine supply, the degree to which this occurs depends on the tissue type. Liver and gut behave differently. In the liver dietary purines increase the activity of salvage and catabolism pathways simultaneously, while the gut, which has only a low capacity for de novo synthesis is dependent on the liver for the supply of nucleotides. Where protein intake is reduced, the salvage pathway assumes a greater importance as a means of recycling purines and pyrimidines released by nucleic acid catabolism. Lack of dietary purines and pyrimidines will switch on de novo synthesis in the gut, to a limited extent.
Within the cell itself, the split between do novo and salvage pathways differs for each species of RNA. Ribosomal RNA production seems to rely more heavily on de novo synthesis than does mRNA or tRNA synthesis. In this sense, an important component of protein synthesis (the ribosome) can be seen to be under the same general nutritional controls as protein synthesis itself, that is the dietary amino acid supply.
The importance of an adequate increase in cellular ribosome synthesis during enterocyte production and maturation can be inferred from the known effects of malnutrition on mucosal architecture and cell kinetics. This relation holds true for many other cell types and there is no reason to believe that the enterocyte is an exception. Its reliance on de novo pathways, and the low levels of these pathways, may make this cell type particularly sensitive to any limitation of purine and pyrimidine supply. This situation will occur in the malnourished patient, or one receiving nutrition support without added purines or pyrimidines. The ability of mice to survive intravenous injections of Candida albicans was shown to be considerably enhanced by the addition of yeast RNA or individual purines and pyrimidines to an otherwise nucleotide free diet.59 60 As described above, this protective effect is dependent on the route of administration because oral nucleotide intake does not result in such avid uptake by the spleen. The most recent study has confirmed that intraperitoneal administration of nucleosides can reduce death, after Staphylococcus aureus innoculation, from 71 to 21% in mice.61 In addition, Kulkarni et al investigated the effects of nucleotide free diets in impairing fatal graft v host reactions in irradiated mice. The mirror to these experiments was to determine the proliferative potential of transplanted lymphocytes in animals receiving nucleotide free and nucleotide supplemented diets.62 Surprisingly, nucleotide free diets were immunosuppressive in that mortality graft v host reactions was significantly reduced. Conversely, nucleotide free diets reduced the responsiveness of lymphocytes to PHA, to a very noticeable extent. These results are similar to those seen in malnourished animals but should be considered with some care. Thus, lymphocyte responsiveness is a measurable aspect of the ability of a cell type to mount its appropriate response but its clinical significance is not clear.
Although it has proved difficult to show clinically significant effects of the nutritional state on immune function,63 the finding that death rates were significantly reduced by nucleotide supplementation is highly suggestive. LIVER 
REGENERATION
Using the 70% hepatectomy model in rats, supplementation of total parenteral nutrition regimens with nucleotides and nucleosides (as 10% of amino acid nitrogen) significantly increased post-operative nitrogen balance (became positive) and whole body protein turnover and synthesis. 64 increased the rate of maturation and growth in the young rat, as assessed by mass, RNA, DNA, and protein concentrations and activity of brush border enzymes. 67 As argued above, a limitation in de novo synthesis may be relieved by input into the salvage pathway. If true, it would reflect an interesting phenomenon because less than 1% of the flux of glutamine seems to go into de novo synthesis.68 If there is a limitation then nucleotide and not glutamine supplementation should relieve any de novo limitation, which can be detected biologically. A recent study69 investigated the effect of total parenteral nutrition supplementation with nucleosides (see above6465) or glutamine on reversal of total parenteral nutrition induced gut atrophy in the rat. Nucleosides alone, or in combination with glutamine significantly increased villus height, total and mucosal jejunal wet weight, protein and RNA and brush border maltase and sucrase. The effects of nucleosides were more potent than those of glutamine alone.
In conclusion, because the gut has a high rate of protein turnover and is uniquely dependent on salvage and exogenous supplies of purines and pyrimidines, limitaion in supply may impair maintenance of the barrier function in the malnourished and stressed patient. Normal diets probably provide sufficient purines and pyrimidines to allow for any such limitation, indeed 'requirements' are probably quite modest given the tight metabolic control of purine synthesis and degradation and low utilisation of dietary sources. Total parenteral nutrition or enteral nutrition is unusual in that no purine/ pyrimidine intake is given.
The few, relevant studies cited above are certainly persuasive and can only serve to promote further studies. It may be particularly fruitful to take animal models of stress in which it is known that the gut (barrier function) or immune system, is affected.
